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1. Introduction 
The gold standard for diagnosis and confirmation of PH is right heart catheterization. But 
right heart catheterization is an invasive procedure, and it associated with morbidity (1.1%) 
and mortality (0.55%)(Hoeper et al. 2006). Although right heart catheterization is the 
method to measure pulmonary arterial pressures, it is not suitable in daily practice to screen 
the possible candidates of PH. Echocardiography is an widely available non-invasive tool, 
and it can offer the information on the structures of hearts and the estimated pressure 
profiles of cardiovascular system. Therefore, echocardiography plays an important role in 
diagnosis and monitoring treatment effects.  
The classification of pulmonary hypertension (PH) includes 5 groups: 1) pulmonary arterial 
hypertension (PAH); 2) pulmonary hypertension owing to left heart disease; 3) pulmonary 
hypertension due to lung disease; 4) chronic thromboembolic pulmonary hypertension; 5) 
miscellaneous.(Simonneau et al. 2009) In the clinical situation, while suspecting a patient 
with PH, it  plays an important role in screening the patients with suspected PH, ruling in or 
out PH due to left heart disease, and evaluating the presence of congenital heart disease. If 
the patient is diagnosed as PAH, echocardiography can afford the semi-quantitative 
methods to evaluate the effects of treatment.  
2. Echocardiography in diagnosis of PH 
2.1 Structures of heart 
Conventional echocardiography can provide the two-dimensional images to evaluate the 
structural abnormalities of heart. Group 2 PH account for the most cases of PH (Oudiz 
2007), therefore examination of the function and structure of left heart is the first thing to do 
in diagnosis of PH. Congenital heart disease is another common cause of PH, and it usually 
can be corrected by surgery. Therefore, it is important in evaluating the gross anatomy of 
left heart, the systolic function of left ventricle, mitral valve and aortic valve disorders, the 
diastolic dysfunction of left heart, and the congenital heart defects. The detail evaluation of 
structural evaluation of heart is beyond the scope of this book. In the beginner of PH, who is 
not the cardiologist, cardiovascular consultant is necessary. But diastolic dysfunction is 
usually overlooked in the clinical practice. The possible clue of isolated diastolic dysfunction 
of left heart is dilated left atrium. If this sign is present and the pulmonary capillary wedge 
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pressure is less than 15 mmHg during right heart catheterization, saline replacement during 
right heart catheterization may uncover the occult diastolic dysfunction.(Hoeper et al. 2009). 
It not uncommon that congenital heart disease cannot be diagnosed by transthoracic 
echocardiography due to limited windows, transesophageal echocardiography is a 
necessary tool in this situation, especially in atrial septal defect and pulmonary vein 
stenosis.  
Because of chronic right ventricular (RV) pressure overload, most patients present with 
enlarged right-side chambers, RV hypertrophy, and reduced global RV systolic 
function.(Bossone et al. 1999) The hallmark of RV pressure overload is systolic flattening of the 
interventricular septum with D-shape of left ventricle (Figure 1A), with reduced diastolic and 
systolic left ventricular volumes, but preserved global left ventricular systolic function. The 
eccentric index of left ventricle, which measured at papillary muscle level of mitral valve in 
paraternal short-axis view, is less than 1. (Figure 1A) Pericardial effusions have also been 
described in PAH patients, and this sign represents higher right atrial pressures, higher 
pulmonary arterial pressures and poor prognosis. (Park et al. 1989) (Figure 1B) 
 
 
 
Fig. 1. Echocardiographic parasternal short-axis view. The interventricular septum is 
flattened due to pressure overload of the right ventricle.  
www.intechopen.com
 Echocardiography in Pulmonary Hypertension 
 
211 
 
Fig. 2. Presence of pericardial effusion in a patient with severe pulmonary arterial 
hypertension. 
2.2 Hemodynamics 
As mentioned before, right heart catheterization is the gold standard in diagnosis of PH, but 
non-invasive Doppler echocardiography can also afford estimates of hemodynamic 
parameters, such as pulmonary arterial pressure, cardiac output, pulmonary vascular 
resistance and pulmonary capillary wedge pressures. Therefore, it is a good screening tool 
in patients with PH.  
2.2.1 Pulmonary arterial pressures 
The hemodynamic criterion of pulmonary hypertension is mean pulmonary arterial pressure 
greater than 25 mmHg by right heart catheterization. Pulmonary arterial pressures can also be 
measured semi-quantitatively by echocardiography.  For calculating pulmonary arterial 
systolic pressures, the first step is to estimate right atrial pressure (RAP), which is evaluate by 
examining the diameter of inferior vena cava. IVC diameter < 2.1 cm that collapses >50% with 
a sniff suggests normal RA pressure of 3 mm Hg (range, 0-5 mm Hg), whereas IVC diameter > 
2.1 cm that collapses < 50% with a sniff suggests high RA pressure of 15 mm Hg (range, 10-20 
mm Hg). In scenarios in which IVC diameter and collapse do not fit this paradigm, an 
intermediate value of 8 mm Hg (range, 5-10 mm Hg) may be used. (Table 1) (Rudski et al. 
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2010) The second step is search the presence of tricuspid regurgitation (TR). When TR is 
present, measurement of the peak TR velocity (VTR) should be performed. Because velocity 
measurements are angle dependent, it is recommended to obtain TR signals from several 
windows and to use the signal with the highest velocity. The third step is calculating 
pulmonary arterial systolic pressure (PASP) by the following equation: 
PASP = RAP+VTR2    (Figure 3) 
 
 
 
Fig. 3. A 51-year-old female, with a history of systemic lupus erythematousus and 
pulmonary arterial hypertension, had an estimated tricuspid regurgitation pressure gradient 
of 54mmHg. After adding estimated right atrial pressure, pulmonary artrerial systolic 
pressure would be obtained. 
But the accuracy of the estimated PASP depends on recording a clear envelope of the TR 
velocity by continuous-wave Doppler tracing. If the signal of TR is not clear or incomplete, 
underestimation of peak velocity of TR will occurs. 
Estimation of pulmonary arterial diastolic pressure (PADP) is similar to that of PASP, and 
the velocity used in estimated PADP is the pulmonary regurgitation (PR) velocity at end-
diastole. The formula to calculate PADP is as following: 
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PADP = RAP+ Vend-diastole PR2   (Figure 4) 
 
Fig. 4. A 51-year-old female, with a history of systemic lupus erythematousus and 
pulmonary arterial hypertension, had an estimated pulmonary regurgitation pressure 
gradient of 32mmHg. After adding estimated right atrial pressure, pulmonary artrerial 
diastolic pressure would be obtained. 
After obtaining PASP and PADP, the mean PA pressure (MPAP) can be obtained as following: 
MPAP = PADP + 1/3 (PASP-PADP)   (Figure 3) 
 
RAP (mmHg) 
Normal 
(0-5) 
Intermediate  
(5-10) 
High (15) 
IVC diameter (mm) < 21 <21 >21 >21 
Collapse with sniff >50% <50% >50% <50% 
Secondary indices 
of elevated RAP 
   
Restrictive filling 
Tricuspid E/E’ > 6 
Diastolic flow predominance in hepatic 
vein (systolic filling fraction < 55%) 
Table 1. Estimation of right atrial pressure (RAP) on the basis of IVC diameter and collapse 
(Rudski et al. 2010) 
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2.2.2 Cardiac output  
Cardiac output is related to the symptoms and prognosis of PH. Cardiac output can also be 
calculated by echocardiography. Before calculating cardiac output, the presumption is 
absence of intra-cardiac or great vessel shunt, and the cardiac output can be measured from 
left ventricular outflow tract (LVOT) or right ventricular outflow tract. In daily practice, 
measurements of diameters and velocity time integral of left ventricular outflow tract is a 
routine practice in our echocardiographic laboratory. Therefore, application of pulse-wave 
Doppler over LVOT, a clear envelope of LVOT flow (VTILVOT) can be acquired. The diameter 
of LVOT (DLVOT) can be measured at parasternal long-axis view. The cardiac output can be 
calculated as the following equation: 
 Cardiac output = 0.785*DLVOT2 * VTILVOT * heart rate/1000  (Figure 5) 
*1000 is for conversion of units 
 
Fig. 5. A 34-year-old male with thalassemia and chronic hemolytic anemia related 
pulmonary hypertension. (VTILVOT: 16.3cm/s, DLVOT: 2.3cm,  
Cardiac output= 0.785*2.32*16.3*66/1000 = 4.4L/min) 
3. Echocardiography in evaluation of right heart function 
Right ventricular function is a prognostic factor of PH. However, because of complex 
geometry of right ventricle, it is difficulty to evaluate right ventricular function. In current 
era, more studies demonstrated the clinical utility and value of right ventricular myocardial 
performance index, tricuspid annular plane systolic excursion (TAPSE), right ventricular 
fractional area changes and Sm of the tricuspid annulus. 
3.1 Right ventricular myocardial performance index (RVMPI) 
RVMPI is an index of global RV function, and it is calculated by summation of isovolumic 
contraction time (IVCT) and isovolumic relaxation time (IVRT) and divided by ejection time 
(ET). (Figure 6) 
IVCT IVRT
RVMPI
ET
  
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Fig. 6. Myocardial TDI includes all 3 phases. The MPI was calculated as (a-b)/b. a: the time 
interval from the onset of isovolumic contraction to the end of isovolumic relaxation;  
Am: late diastolic wave; b = ventricular ejection time; Em: early diastolic wave; EKG: 
electrocardiogram; IVCT : isovolumic contraction time; IVRT: isovolumic relaxation time; 
Sm: the wave for the systolic phase. 
It can be obtained by flow-Doppler and tissue Doppler technique. By using flow-Doppler 
technique, pulse-wave Doppler tracings are obtained from tricuspid valve and right 
ventricular outflow tract. By using tissue-Doppler technique, IVCT, IVRT and ET are 
obtained from the lateral tricuspid annulus. (Figure 6) RVMPI > 0.40 by flow-Doppler 
technique and > 0.55 by tissue-Doppler technique indicate RV systolic dysfunction. (Rudski 
et al. 2010) 
3.2 Tricuspid annulus plane systolic excursion (TAPSE) 
Although the morphology of RV is complex, contraction of the longitudinal fibers of RV 
cause most of RV systolic function and measurement of RV longitudinal motion can 
represent RV systolic function. TAPSE is an easy and convenient way to evaluate the RV 
longitudinal motion. In apical four-chamber view, the cursor line is placed across the lateral 
tricuspid annulus, and M-mode imaging of the cursor line reveals the longitudinal motion 
of lateral tricuspid annulus. TAPSE is the distance, which tricuspid annulus moves from the 
end-diastole phase to the end-systolic phase, and it represents the RV systolic function. 
When TAPSE < 16mm, RV systolic dysfunction may be present. (Figure 7) 
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Fig. 7. A 35-year-old female with a history of idiopathic pulmonary arterial hypertension, 
with low TAPSE (13mm), which indicates poor RV systolic function  
3.3 Right ventricular fractional area change (RVFAC) 
RVFAC, which resembles left ventricular ejectional fraction, provides an estimate of RV 
systolic function. To obtain RVFAC, clear RV morphology and endocardial border should be 
clear at apical four-chamber views. RV end-diastolic and end-systolic areas (RVEDA & 
RVESA) are obtained after tracing RV area. 
100%
RVEDA RVESA
RVFAC
RVEDA
   
RVFAC > 40% is normal. RVFAC <35% indicates RV systolic dysfunction. It is important to 
make sure that the entire right ventricle is in the view, including the apex and the lateral 
wall in both systole and diastole. Care must be taken to exclude trabeculations while tracing 
the RV area. 
3.4 Peak Sm of lateral tricuspid annulus 
Although tissue Doppler imaging detects regional myocardium function, pulmonary 
hypertension causes global RV change and lateral tricuspid annulus function can represent 
global RV function. Peak Sm of lateral tricuspid annulus is obtained by tissue-Doppler 
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technique at end-expiration period. Peak Sm> 10 cm/s is normal, and peak Sm< 10cm/s 
represents depressed RV systolic function. (Figure 8) 
 
Fig. 8. A 45-year-old female with systemic lupus erythematosus and pulmonary arterial 
hypertension, had a low peak Sm (6.0cm/s) at lateral tricuspid annulus, which indicates 
poor RV systolic function.  
4. Conclusion 
Echocardiography is a useful tool in diagnosis of PH, evaluating the left heart disease, and 
estimation of pulmonary arterial hemodynamics. After diagnosis of PH is established, 
TAPSE, peak Sm velocity and RVMPI are simple methods to monitor treatment effects.  
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